# A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas

> **NCT01140737** · PHASE2 · COMPLETED · sponsor: **Sheffield Teaching Hospitals NHS Foundation Trust** · enrollment: 145 (actual)

## Conditions studied

- Soft Tissue Sarcoma

## Interventions

- **DRUG:** Axitinib

## Key facts

- **NCT ID:** NCT01140737
- **Lead sponsor:** Sheffield Teaching Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08-31
- **Primary completion:** 2016-06-11
- **Final completion:** 2019-01-08
- **Target enrollment:** 145 (ACTUAL)
- **Last updated:** 2021-03-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01140737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01140737, "A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01140737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*